CureVac N.V. (ETR:5CV)
2.858
+0.012 (0.42%)
Apr 24, 2025, 5:35 PM CET
CureVac Revenue
In the year 2024, CureVac had annual revenue of 535.18M EUR with 895.54% growth. CureVac had revenue of 254.19M in the quarter ending December 31, 2024, with 1,026.36% growth.
Revenue
535.18M
Revenue Growth
+895.54%
P/S Ratio
1.17
Revenue / Employee
592.01K
Employees
983
Market Cap
627.88M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
CureVac News
- 14 days ago - CureVac N.V. (CVAC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - CureVac BV reports Q4 results - Seeking Alpha
- 14 days ago - CureVac N.V. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 14 days ago - CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update - Wallstreet:Online
- 14 days ago - CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update - Accesswire
- 14 days ago - CureVac: 2024 Financial Results & Business Update Unveiled - Wallstreet:Online
- 14 days ago - EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update - Wallstreet:Online
- 14 days ago - Earnings Scheduled For April 10, 2025 - Benzinga